Leadership - Management, Advisers & Board

Mike Mills

President and Interim Chief executive OfficeR

Over 20 years in the Manufacturing, Media and Financial Services industries in senior roles.

Over 10 years with the Financial Post and National Post newspapers.

Bachelor of Business Administration from Bishop’s University

 

Dong H Shim

Chief Financial Officer and director

Mr. Shim is a Chartered. Professional Accountant in Canada and a Registered Certified Public Accountant in the state of Illinois, USA.

Currently the President and founder of both SHIM Accounting Corporation and Golden Tree Capital Corp.

Serves as the CFO for International Private Vault Inc. and as a director of National Issuer Services Ltd., a transfer agent company based in British Columbia, Canada.

Trip Hoffman

Chief Operating Officer

Past CEO of a Colorado licensed cultivation and dispensary company and operations-efficiency specialist in the cannabis space.

Over 20 years in the Financial Technology & Services industry in roles ranging from CEO, Risk Manager, to Market Maker.

PhD in physics from Purdue University and studied at Cornell University and Northwestern University during his education.

Brent Reuter

Director

Senior Vice President Investor Relations an Strategy for Australis Capital Inc.

Mr. Reuter has held positions as principal investor relations for Onex Corp., a private equity firm, vice-president of asset management for Canadian Imperial Bank of Commerce and as managing director at Royal Bank of Canada with roles in Hong Kong and New York. In these roles, he built high-value client and strategic partnerships, recruited and developed sales teams, and implemented and executed high-impact revenue coverage models.

Appointed to the Board of Body and Mind pursuant to nominee rights granted to Australis pursuant to its strategic investment into Body and Mind.

David Wenger

Director

Mr. Wenger is an accomplished lawyer and for 13 years he represented foreign government and major corporate clients in high-stakes complex cross-border disputes and transactions.

Member of the US Senate Cannabis Working Group and the US House of Representatives Cannabis Working Group. In those roles, he has the historic opportunity to work with senior Congressional staffers on advancing federal cannabis legislation.

Mr. Wenger wrote a seminal White Paper on the US cannabis industry widely read across the world: The Green Regulatory Arbitrage: A Case for Investing in US Multi-State Vertically-Integrated Cannabis Companies.

Robert Hasman

Director

Managing Director, Sperry Van Ness, a NV commercial real estate brokerage firm..

Involved in the origination and
syndication of more than $1b of commercial real estate acquisitions.

Over 10 years of experience in
business development and
operations.
Pioneer in the Nevada MJ market.

Bachelor of Arts, Ohio State University.

Kevin C. Hooks

Director

Founder and former CEO of Catalyst  RX, a pharmacy benefit manager.

In 2001, Catalyst RX went public on  Nasdaq under CRTX.

By 2012, CHSI revenues exceeded  USD $5B and the company joined  Fortune 500.

Later in 2012, the company achieved  over $5B in sales and was sold for USD $4.4B.

Bachelor of science, Ohio State  University.

Board certified pharmacist.

Qualifying Conditions

  • Cancer
  • Glaucoma
  • Positive status for human immunodeficiency virus/acquired immune deficiency syndrome
  • Hepatitis C
  • Amyotrophic lateral sclerosis
  • Tourette’s syndrome
  • Crohn’s disease
  • Ulcerative colitis
  • Post-traumatic stress disorder
  • Severe arthritis
  • Fibromyalgia
  • Alzheimer’s disease
  • Cachexia or wasting syndrome
  • Peripheral neuropathy
  • Intractable pain which is pain that has not responded to ordinary medications, treatment or surgical measures for more than six (6) months
  • Severe nausea
  • Seizures including without limitation those characteristic of epilepsy
  • Severe and persistent muscle spasms including without limitation those characteristic of multiple sclerosis and any other medical condition or its treatment approved by the Department of Health.